109 studies found for:    Open Studies | "Nephritis"
Show Display Options
Rank Status Study
21 Recruiting AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin
Condition: Lupus Nephritis
Interventions: Drug: Voclosporin High Dose;   Drug: Voclosporin Low Dose;   Drug: Placebo
22 Recruiting Hereditary Tubulointerstitial Nephritis
Conditions: Nephritis, Interstitial;   Chronic Renal Failure;   Gout;   Renal Cysts
Intervention: Other: Blood and urine sample collections
23 Recruiting Long-Term Study of Multi-target Therapy as Continuous Induction and Maintenance Treatment for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus+mycophenolate mofetil;   Drug: Azathioprine
24 Recruiting Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy
Condition: Lupus Nephritis
Intervention: Biological: Rituximab
25 Recruiting Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Diabetic Nephropathy;   Lupus Nephritis;   Glomerulonephritis, IGA
Intervention:
26 Not yet recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab
27 Recruiting Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists
Conditions: Hospitalized Cases of Angioneurotic Oedema;   Pneumonia;   Gastroenteritis;   Failure to Thrive;   Seizures;   Acute Interstitial Nephritis and Thrombocytopenia
Intervention:
28 Unknown  Cyclophosphamide in Lupus Nephritis
Condition: Systemic Lupus Erythematosus
Intervention:
29 Recruiting The Effect of Calcitriol on Progress and Activity of Lupus Nephritis
Condition: Systemic Lupus Erythematosus
Interventions: Drug: calcitriol;   Drug: placebo
30 Recruiting ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Condition: SLE Glomerulonephritis Syndrome, WHO Class V
Intervention: Drug: Acthar gel
31 Not yet recruiting CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Blisibimod;   Drug: Placebo
32 Recruiting Alport Syndrome Treatments and Outcomes Registry
Condition: Alport Syndrome
Intervention:
33 Recruiting ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition: Alport Syndrome Patients With Measured GFR Between 30-75 ml/Min
Intervention:
34 Recruiting Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy
Condition: Hypertension Secondary to Renal Disease
Intervention: Procedure: Renal nerve denervation
35 Recruiting Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children
Conditions: Renal Insufficiency;   Infection
Interventions: Drug: Low-dose intravenous cyclophosphamide;   Drug: High-dose intravenous cyclophosphamide
36 Not yet recruiting Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis
Condition: Pyelonephritis
Intervention: Other: No intervention
37 Not yet recruiting Bacterial and Host Genetic Risk Factors in Acute Pyelonephritis
Condition: Vesicoureteral Reflux
Intervention:
38 Recruiting Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
Conditions: Urinary Tract Infections;   Pyelonephritis
Interventions: Drug: MK-7655 250 mg;   Drug: MK-7655 125 mg;   Drug: imipenem/cilastatin 500 mg;   Drug: Placebo to MK-7655
39 Not yet recruiting Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria
Conditions: Asymptomatic Bacteriuria;   Pyelonephritis
Interventions: Drug: Antibiotic treatment;   Other: No treatment
40 Recruiting Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Uncomplicated Pyelonephritis Due to Extended-spectrum β-lactamase Producing Escherichia Coli
Condition: Uncomplicated Pyelonephritis Due to ESBL-producing E.Coli
Intervention: Drug: Cefoxitin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years